Cardiovascular, Kidney, and Metabolic Health Assessment with Patient Empowerment

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional project combines CHAPERONE AI, CKMiq AI, a Copilot LLM, and remote vital‑sign monitoring devices with biomarker‑driven algorithms to support care coordination and patient self‑management. Participants are adults with diabetes (A1c ≥7.5), recent coronary stent placement or CABG within 12 months, CKD stage 2–4, or recent heart‑failure hospitalization, enrolled at sites in Chandler, Gilbert, and Phoenix, Arizona. The program integrates digital coaching, automated risk scores from diagnostics, and sensor data to personalize treatment strategies and prompt clinical follow‑up. Primary outcomes target reduction in CKM disease burden and improvements in quality of life and healthcare utilization.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Men and women over 18 years of age are included
* Eligible subjects must have one of the risk factor/ disease component of CKM:
* Diabetes with A1C of 7.5 or higher;
* or Heart disease with stent placement;
* or Coronary Artery Bypass Graft (CABG) in the last 12 months;
* or Chronic Kidney Disease (CKD) stage 2- 4
* and, in those with Heart failure, a recent hospitalization within one week of enrollment is required

Exclusion Criteria:

* Those subjects who are not willing to sign an informed consent

Where it's running

• Gilbert Cardiology
  Gilbert, Arizona, United States Recruiting
• Arizona Heart Foundation
  Phoenix, Arizona, United States Recruiting
• Fountains Family Care
  Chandler, Arizona, United States Completed
• East Valley Diabetes
  San Tan Valley, Arizona, United States Completed
• Karolinska University Hospital
  Stockholm, Sweden Not yet recruiting

Study contacts

• Principal investigator: Zaki Lababidi PI, MD — Gilbert Cardiology
• Study coordinator: Navin Govind Steering Committtee, MS
• Email: info@aventyn.com
• Phone: 2317942328

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Adapting and testing PEN-Plus in Zambian primary care

  Aiming to see if the PEN-Plus package can be adapted and used in two Zambian hospitals to better manage chronic diseases like heart disease, diabetes, hypertension, and sickle cell in primary care.

  Recruiting Centre for Infectious Disease Research in Zambia · Lusaka, Lusaka Province · NCT07753681

• Impact of a Clinical Information System on hospital outcomes for adults with chronic diseases

  This study tests whether implementing a Clinical Information System helps reduce readmissions or death within 30 days after hospital discharge for adults with chronic conditions in Alberta.

  Recruiting University of Calgary · Calgary, Alberta · NCT07609381

• Investigating the effects of glucose-lowering and immunosuppressive therapies on immune response in diabetes and kidney disease

  This study is testing if new diabetes medications can lower harmful immune responses in people with diabetes and kidney disease to help prevent serious complications.

  Recruiting Western Galilee Hospital-Nahariya · Nahariya · NCT06821919

• Using Apple Watch data to predict heart failure outcomes

  This study is testing if data from Apple Watches can help predict heart failure problems and the chances of needing to go back to the hospital for patients with heart failure.

  Recruiting University Medical Center Goettingen · Goettigen, Lower Saxony · NCT06819618

• Reliability of Two-Stage Multiple-Repetition-Maximum Tests to Estimate 1-RM in People with Heart Disease and Risk Factors

  This study checks how well different formulas estimate the 1-RM from two submaximal tests in adults with heart disease or risk factors.

  Recruiting Technical University of Munich · München · NCT06796582

• Integrated care for older patients with atrial fibrillation

  This study is testing a new team-based care approach for older patients with atrial fibrillation and other health issues to see if it helps them manage their condition better than regular care.

  Recruiting at 50 sites Heart Care Foundation · Haskovo and 49 other locations · NCT06775028

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.